Parkinson’s is a complex disease that affects multiple systems in the central nervous system, with the most prominent symptoms being slowness of movement (bradykinesia), tremor, and gait abnormalities. However, there are a multitude of other symptoms, including fatigue, depression, and anxiety.
A recent study appears to demonstrate markers of inflammation in the cerebrospinal fluid of Parkinson’s patients, and these markers appear to correlate with depression, anxiety and cognitive impairment.
While this information does not change any treatment of Parkinson’s at this time, there is always hope that new information will lead to additional effective treatments. Click here to review article about: Parkinson’s severity